This is out Library. Please click on the article title to view the details.
submitted by: admin on 06/18/2016
In a field plagued by frequent controversy, the American Cancer Society (ACS) claims to have taken a major step forward to provide transparency in how justified it is in recommending cancer screening tests. It blames oncologists with a conflict of interest...what would you expect from an organization that depends on income from big pharma and the mammography...
submitted by: admin on 09/19/2013
BPH begins at age 50 and may lead to urinary obstruction. Differentiation from prostate cancer can be difficult. The use of the PSA test is controversial
submitted by: admin on 09/19/2013
Cancer is on the rise and cancer screening is being promoted. Early detection is not as important as you'd think. The pap smear, mammograms, colonoscopy, and PSA testing have major problems that lead to over or underdiagnosis and unnecessary treatment. Screens over the age of 70 has not been shown to be warranted.
submitted by: admin on 09/21/2013
The FDA is requiring that Avodart and Proscar manufacturers disclose that there is an approximately 50% increased incidence of high grade prostate cancer with their usage. It also pointed out that they are not approved for prostate cancer prevention. These drugs block the conversion of testosterone to dihydro-testosterone, which is believed to be one the causes...
submitted by: admin on 06/24/2016
Vitamin D may increase longevity in people with cancer according to an article from the Chinese Academy of Sciences in Shanghai in the April 2014 issue of the Journal of Clinical Endocrinoloogy and Metabolism. Scientists measured vitamin D levels in more than 17,000 patients diagnosed wth cancer and found that those with higher levels had better survival...
submitted by: admin on 06/30/2016
For men with localized prostate cancer, surgery does not save lives and it has a much higher rate of complications such as impotence and incontenance. However, once a man knows he has prostate cancer, he has a powerful drive to get it out even if the data does not support this approach. The word, "cancer" scares us.
We need much better...
submitted by: admin on 10/06/2024
Dr. Len and Nurse Vicki explore the following topics:
Health care reform
Schemes to cut Medicare costs
Environmental pollution
Prostate cancer screening: does it pay off?
Using digitalis to treat breast and prostate cancer
Antidepressants found to cause arteriosclerosis
The benefits of maple syrup
Vicki's 20-20 tips
Greenwashers
unwanted...
submitted by: admin on 04/08/2015
Most men will get prostate cancer during their life time. That's right, if you live to be 90 years old your risk is 90%! If you live to age 50, 50% will have prostate. However, 98% of prostate cancers do not need treatment because we die with them, not from them! The trick is to tell who is in the 2% that will die from it. With new technologies coming into...
submitted by: admin on 02/17/2015
The PSA era is over. Modern research has shown that it leads to overdiagnosis and overtreatment and far too many surgeries, radiation therapy, and hormonal therapy. Prostate cancer is very common, but only about 2% need to be treated. Preventive measures and environmental toxins are reviewed. The relationship of various hormones is discussed.New tools...
submitted by: admin on 10/14/2013
Dr. Len and Dr. Kunin talk about prostate cancer and some manifestations of it. There have been big changes in how we look at prostate cancer in the last several years. The whole era of the PSA test is now over according to Thomas Stamey, the inventor of the test. We have now gotten to a situation where we are over treating most men who have...
submitted by: admin on 06/18/2016
The inventor of the PSA test as come out and stated that the PSA era is over. We are over-diagnosing too many prostate cancers that don't need treatment with the test. There is no good prostate screening test today. The PSA test is good for following known prostate cancers as they are a good measurement of the extent of growth of the cancer.
submitted by: admin on 10/06/2024
Should PSA screening be removed from prostate cancer guidelines? Some researchers have found that a change of PSA levels over time is a poor predictor of prostate cancer and may lead to many unnecessary biopsies.
submitted by: admin on 10/06/2024
The PSA era is over. Modern research has shown that it leads to overdiagnosis and overtreatment and far too many surgeries, radiation therapy, and hormonal therapy. Prostate cancer is very common, but only about 2% need to be treated. Preventive measures and environmental toxins are reviewed. The relationship of various hormones is discussed.New tools for diagnosis...
submitted by: admin on 10/14/2013
Screening does not significantly reduce prostate cancer deaths but it does lead to overdetection and overtreatment. The cancer detection rate is 40% higher with testing, but to prevent one death from prostate cancer more than 1400 men would need screening and 48 would be unnecessarily treated. The era of the PSA is over.
submitted by: admin on 06/18/2016
Medical professional groups and cancer advocacy groups need to refocus on educating rather than persuading about cancer testing. The harms of screening have been largely dismissed. It is easy to sell screening, just magnify the benefit, minimize the cost, and hide the data about their value.
These tests are big business and there are conflicts...
submitted by: admin on 06/25/2016
Many breast cancers resolve on their own. Autopsy studies show that about 30% of women in their 50s have occult breast cancers that apparently come and go. It makes one wonder if we are massively overdiagnosing cancers and overtreating them as well. The trick is to know which cancers are dangerous and in need of treatment. Studies on mammograms over time have...